What is the current annual EBITDA of ARWR?

As of today, ARWR annual EBITDA is $122.27M

What is 1-year change in ARWR annual EBITDA?

ARWR annual EBITDA is up +120.99% year-over-year

What is 3-year change in ARWR annual EBITDA?

ARWR annual EBITDA is up +172.74% over the past 3 years

How far is ARWR annual EBITDA from its all-time high?

ARWR annual EBITDA is currently at its all-time high

How does ARWR annual EBITDA rank versus sector peers?

ARWR annual EBITDA is higher than 84.83% of companies in Healthcare sector

When is ARWR next annual earnings release?

The next annual earnings release for ARWR is on November 24, 2026

What is the current quarterly EBITDA of ARWR?

As of today, ARWR quarterly EBITDA is -$163.43M

What is ARWR quarterly EBITDA most recent change?

ARWR quarterly EBITDA was down -21.16% on June 30, 2026

What is 1-year change in ARWR quarterly EBITDA?

ARWR quarterly EBITDA is down -2.58% year-over-year

How far is ARWR quarterly EBITDA from its all-time high?

ARWR quarterly EBITDA is currently -142.20% below its historical high of $387.29M set on March 31, 2025

How does ARWR quarterly EBITDA rank versus sector peers?

ARWR quarterly EBITDA is higher than 0.95% of companies in Healthcare sector

When is ARWR next earnings release?

The next earnings release for ARWR is on November 24, 2026

What is the current TTM EBITDA of ARWR?

As of today, ARWR TTM EBITDA is -$200.64M

What is ARWR TTM EBITDA most recent change?

ARWR TTM EBITDA was down -2.09% on June 30, 2026

What is 1-year change in ARWR TTM EBITDA?

ARWR TTM EBITDA is down -134.95% year-over-year

How far is ARWR TTM EBITDA from its all-time high?

ARWR TTM EBITDA is currently -161.61% below its historical high of $325.65M set on December 31, 2025

How does ARWR TTM EBITDA rank versus sector peers?

ARWR TTM EBITDA is higher than 8.16% of companies in Healthcare sector

When is ARWR next earnings release?

The next earnings release for ARWR is on November 24, 2026

ARWR EBITDA History & Chart Since 1997

Annual EBITDA

$122.27M$704.76M+120.99%

September 30, 2025

Summary

Current Value: As of today, ARWR annual EBITDA is $122.27M, up +120.99% on September 30, 2025
Historical Performance: ARWR annual EBITDA is up +172.74% over the past 3 years, up +240.20% over the past 5 years
All-Time High Comparison: ARWR annual EBITDA is currently at its all-time high
3-Year Low Comparison: ARWR annual EBITDA is +120.99% above its 3-year low of -$582.49M reached on September 30, 2024
Sector Comparison: ARWR annual EBITDA is higher than 84.83% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

ARWR Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Sep 30, 25	$122.27M	+121.0%	+172.7%	+240.2%	+1600.8%
Quarterly EBITDA	Jun 30, 26	-$163.43M	-2.6%	-64.4%	-447.2%	-9492.9%
TTM EBITDA	Jun 30, 26	-$200.64M	-134.9%	-18.6%	-58.3%	-2934.7%
Price	Aug 28, 26	$84.91	+280.1%	+207.0%	+28.5%	+1632.9%
PE Ratio	Aug 28, 26	-	–	–	–	–
Annual Revenue	Sep 30, 25	$829.45M	+10000.0%	+241.0%	+842.6%	+10000.0%
Annual EPS	Sep 30, 25	-$0.01	+99.8%	+99.3%	+98.5%	+98.8%
	Sep 30, 25	$98.35M	+116.4%	+155.1%	+205.6%	+1217.3%
Annual Net Income	Sep 30, 25	$30.11M	+104.9%	+117.1%	+135.6%	+507.8%

EBITDA Highs

ARWR Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$122.27M	Sep 30, 25	at high
5Y	$122.27M	Sep 30, 25	at high
All	$122.27M	Sep 30, 25	at high

EBITDA Lows

ARWR Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	-$582.49M	Sep 30, 24	+121.0%
5Y	-$582.49M	Sep 30, 24	+121.0%
All	-$582.49M	Sep 30, 24	+121.0%

EBITDA History

Year	Value	Change
2025	$122.27M	+121.0%
2024	-$582.49M	-202.6%
2023	-$192.51M	-14.5%
2022	-$168.09M	-19.4%
2021	-$140.77M	-61.4%
2020	-$87.22M	-232.9%
2019	$65.63M	+228.1%
2018	-$51.24M	-58.6%
2017	-$32.31M	+60.7%
2016	-$82.29M	-0.8%
2015	-$81.60M	-72.5%
2014	-$47.30M	-135.2%
2013	-$20.11M	-4.0%
2012	-$19.34M	-102.3%
2011	-$9.56M	-17.4%

Year	Value	Change
2010	-$8.15M	+50.4%
2009	-$16.44M	+46.3%
2008	-$30.59M	-11.9%
2007	-$27.35M	-39.6%
2006	-$19.60M	-124.8%
2005	-$8.72M	-223.6%
2004	-$2.69M	-2,754.0%
2003	-$94.40K	+28.8%
2002	-$132.50K	-29.0%
2001	-$102.70K	-1.1%
2000	-$101.60K	-111.2%
1999	-$48.10K	-100.4%
1998	-$24.00K	+56.2%
1997	-$54.80K	-

FAQ

What is the current annual EBITDA of ARWR?: As of today, ARWR annual EBITDA is $122.27M
What is 1-year change in ARWR annual EBITDA?: ARWR annual EBITDA is up +120.99% year-over-year
What is 3-year change in ARWR annual EBITDA?: ARWR annual EBITDA is up +172.74% over the past 3 years
How far is ARWR annual EBITDA from its all-time high?: ARWR annual EBITDA is currently at its all-time high
How does ARWR annual EBITDA rank versus sector peers?: ARWR annual EBITDA is higher than 84.83% of companies in Healthcare sector
When is ARWR next annual earnings release?: The next annual earnings release for ARWR is on November 24, 2026

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

-$163.43M$28.54M-21.16%

June 30, 2026

Summary

Current Value: As of today, ARWR quarterly EBITDA is -$163.43M, down -21.16% on June 30, 2026
Historical Performance: ARWR quarterly EBITDA is down -2.58% year-over-year, down -64.37% over the past 3 years
All-Time High Comparison: ARWR quarterly EBITDA is currently -142.20% below its historical high of $387.29M set on March 31, 2025
3-Year Low Comparison: ARWR quarterly EBITDA is +4.62% above its 3-year low of -$171.36M reached on June 30, 2024
Sector Comparison: ARWR quarterly EBITDA is higher than 0.95% of companies in Healthcare sector

Performance

ARWR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	-$163.43M	-21.2%	-2.6%	-64.4%	-447.2%
Annual EBITDA	Sep 30, 25	$122.27M	–	+121.0%	+172.7%	+240.2%
TTM EBITDA	Jun 30, 26	-$200.64M	-2.1%	-134.9%	-18.6%	-58.3%
Price	Aug 28, 26	$84.91	+7.4%	+280.1%	+207.0%	+28.5%
PE Ratio	Aug 28, 26	-	–	–	–	–
Quarterly Revenue	Jun 30, 26	$75.25M	+2.1%	+171.0%	+375.5%	+64.0%
Quarterly EPS	Jun 30, 26	-$1.36	-45.4%	-7.5%	-40.8%	-371.3%
	Jun 30, 26	-$170.09M	-20.4%	-2.7%	-65.6%	-433.7%
Quarterly Net Income	Jun 30, 26	-$178.92M	-30.1%	-0.1%	-71.8%	-497.9%

Quarterly EBITDA Highs

ARWR Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$50.49M	Sep 30, 25	-423.7%
3Y	$387.29M	Mar 31, 25	-142.2%
5Y	$387.29M	Mar 31, 25	-142.2%
All	$387.29M	Mar 31, 25	-142.2%

Quarterly EBITDA Lows

ARWR Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	-$163.43M	Jun 30, 26	at low
3Y	-$171.36M	Jun 30, 24	+4.6%
5Y	-$171.36M	Jun 30, 24	+4.6%
All	-$171.36M	Jun 30, 24	+4.6%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	-$163.43M	-21.2%
Mar 2026	-$134.89M	-385.8%
Dec 2025	$47.20M	-6.5%
Sep 2025	$50.49M	+131.7%
Jun 2025	-$159.33M	-141.1%
Mar 2025	$387.29M	+348.0%
Dec 2024	-$156.18M	+0.6%
Sep 2024	-$157.18M	+8.3%
Jun 2024	-$171.36M	-40.8%
Mar 2024	-$121.67M	+8.0%
Dec 2023	-$132.28M	-26.6%
Sep 2023	-$104.47M	-5.1%
Jun 2023	-$99.43M	-295.6%
Mar 2023	$50.84M	+228.9%
Dec 2022	-$39.45M	+51.4%
Sep 2022	-$81.17M	-15.5%
Jun 2022	-$70.31M	-259.3%
Mar 2022	$44.14M	+172.7%
Dec 2021	-$60.75M	+2.6%
Sep 2021	-$62.38M	-108.9%
Jun 2021	-$29.87M	-13.4%
Mar 2021	-$26.33M	-18.5%
Dec 2020	-$22.23M	+54.0%
Sep 2020	-$48.34M	-235.5%
Jun 2020	-$14.41M	+31.0%
Mar 2020	-$20.87M	-480.7%
Dec 2019	-$3.59M	-133.5%
Sep 2019	$10.72M	-45.3%
Jun 2019	$19.60M	-15.5%
Mar 2019	$23.19M	+91.3%
Dec 2018	$12.12M	+222.0%
Sep 2018	-$9.94M	+32.6%
Jun 2018	-$14.74M	-6.2%
Mar 2018	-$13.88M	-9.5%
Dec 2017	-$12.67M	-39.3%
Sep 2017	-$9.10M	-99.8%
Jun 2017	-$4.55M	+7.9%
Mar 2017	-$4.94M	+64.0%
Dec 2016	-$13.72M	+44.6%
Sep 2016	-$24.76M	-33.7%
Jun 2016	-$18.52M	+9.5%
Mar 2016	-$20.46M	-10.3%
Dec 2015	-$18.55M	+17.5%
Sep 2015	-$22.48M	-47.4%
Jun 2015	-$15.25M	+19.9%
Mar 2015	-$19.04M	+23.3%
Dec 2014	-$24.83M	-41.6%
Sep 2014	-$17.54M	-41.1%
Jun 2014	-$12.42M	-14.9%
Mar 2014	-$10.82M	-63.7%
Dec 2013	-$6.61M	-6.9%
Sep 2013	-$6.18M	-33.5%
Jun 2013	-$4.63M	+6.4%
Mar 2013	-$4.94M	-13.3%
Dec 2012	-$4.36M	+11.6%

Month	Value	Change
Sep 2012	-$4.93M	+22.7%
Jun 2012	-$6.38M	-43.5%
Mar 2012	-$4.44M	-26.5%
Dec 2011	-$3.51M	-23.4%
Sep 2011	-$2.85M	-67.2%
Jun 2011	-$1.70M	+2.7%
Mar 2011	-$1.75M	-97.4%
Dec 2010	-$887.00K	+60.9%
Sep 2010	-$2.27M	-8.8%
Jun 2010	-$2.09M	-1.7%
Mar 2010	-$2.05M	+1.5%
Dec 2009	-$2.08M	+35.5%
Sep 2009	-$3.23M	-45.2%
Jun 2009	-$2.22M	+30.0%
Mar 2009	-$3.18M	+36.3%
Dec 2008	-$4.99M	+56.5%
Sep 2008	-$11.46M	-19.0%
Jun 2008	-$9.63M	-42.1%
Mar 2008	-$6.78M	-2.7%
Dec 2007	-$6.60M	+41.9%
Sep 2007	-$11.36M	+13.6%
Jun 2007	-$13.14M	-60.3%
Mar 2007	-$8.20M	-93.2%
Dec 2006	-$4.24M	+43.5%
Sep 2006	-$7.51M	-76.5%
Jun 2006	-$4.25M	-12.9%
Mar 2006	-$3.77M	+1.5%
Dec 2005	-$3.82M	-131.0%
Sep 2005	-$1.66M	+47.8%
Jun 2005	-$3.17M	-69.3%
Mar 2005	-$1.87M	-0.9%
Dec 2004	-$1.86M	-30.2%
Sep 2004	-$1.43M	-140.0%
Jun 2004	-$594.10K	-11.9%
Mar 2004	-$531.10K	-273.2%
Dec 2003	-$142.30K	-529.6%
Sep 2003	-$22.60K	-68.7%
Jun 2003	-$13.40K	+51.8%
Mar 2003	-$27.80K	+9.2%
Dec 2002	-$30.60K	-865.0%
Sep 2002	$4,000.00	+109.1%
Jun 2002	-$43.90K	-96.0%
Mar 2002	-$22.40K	+12.8%
Dec 2001	-$25.70K	-4,183.3%
Sep 2001	-$600.00	+96.1%
Jun 2001	-$15.50K	+34.9%
Mar 2001	-$23.80K	+27.9%
Dec 2000	-$33.00K	-26.0%
Sep 2000	-$26.20K	-24.2%
Jun 2000	-$21.10K	+9.8%
Mar 2000	-$23.40K	+24.3%
Dec 1999	-$30.90K	-2,675.0%
Sep 1999	$1,200.00	+107.2%
Jun 1999	-$16.60K	-16.9%
Mar 1999	-$14.20K	-

FAQ

What is the current quarterly EBITDA of ARWR?: As of today, ARWR quarterly EBITDA is -$163.43M
What is ARWR quarterly EBITDA most recent change?: ARWR quarterly EBITDA was down -21.16% on June 30, 2026
What is 1-year change in ARWR quarterly EBITDA?: ARWR quarterly EBITDA is down -2.58% year-over-year
How far is ARWR quarterly EBITDA from its all-time high?: ARWR quarterly EBITDA is currently -142.20% below its historical high of $387.29M set on March 31, 2025
How does ARWR quarterly EBITDA rank versus sector peers?: ARWR quarterly EBITDA is higher than 0.95% of companies in Healthcare sector
When is ARWR next earnings release?: The next earnings release for ARWR is on November 24, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

-$200.64M$4.11M-2.09%

June 30, 2026

Summary

Current Value: As of today, ARWR TTM EBITDA is -$200.64M, down -2.09% on June 30, 2026
Historical Performance: ARWR TTM EBITDA is down -134.95% year-over-year, down -18.57% over the past 3 years
All-Time High Comparison: ARWR TTM EBITDA is currently -161.61% below its historical high of $325.65M set on December 31, 2025
3-Year Low Comparison: ARWR TTM EBITDA is +66.91% above its 3-year low of -$606.38M reached on December 31, 2024
Sector Comparison: ARWR TTM EBITDA is higher than 8.16% of companies in Healthcare sector

Performance

ARWR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	-$200.64M	-2.1%	-134.9%	-18.6%	-58.3%
Annual EBITDA	Sep 30, 25	$122.27M	–	+121.0%	+172.7%	+240.2%
Quarterly EBITDA	Jun 30, 26	-$163.43M	-21.2%	-2.6%	-64.4%	-447.2%
Price	Aug 28, 26	$84.91	+7.4%	+280.1%	+207.0%	+28.5%
PE Ratio	Aug 28, 26	-	–	–	–	–
TTM Revenue	Jun 30, 26	$669.50M	+7.6%	+16.9%	+161.3%	+522.0%
TTM EPS	Jun 30, 26	-$2.24	-4.4%	-77.5%	-31.3%	-83.8%
	Jun 30, 26	-$226.44M	-2.0%	-109.7%	-25.4%	-68.6%
TTM Net Income	Jun 30, 26	-$272.13M	-0.1%	-70.8%	-47.7%	-116.1%

TTM EBITDA Highs

ARWR TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$325.65M	Dec 31, 25	-161.6%
3Y	$325.65M	Dec 31, 25	-161.6%
5Y	$325.65M	Dec 31, 25	-161.6%
All	$325.65M	Dec 31, 25	-161.6%

TTM EBITDA Lows

ARWR TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	-$200.64M	Jun 30, 26	at low
3Y	-$606.38M	Dec 31, 24	+66.9%
5Y	-$606.38M	Dec 31, 24	+66.9%
All	-$606.38M	Dec 31, 24	+66.9%

TTM EBITDA History

Month	Value	Change
Jun 2026	-$200.64M	-2.1%
Mar 2026	-$196.53M	-160.3%
Dec 2025	$325.65M	+166.3%
Sep 2025	$122.27M	+243.2%
Jun 2025	-$85.40M	+12.3%
Mar 2025	-$97.43M	+83.9%
Dec 2024	-$606.38M	-4.1%
Sep 2024	-$582.49M	-9.9%
Jun 2024	-$529.78M	-15.7%
Mar 2024	-$457.85M	-60.5%
Dec 2023	-$285.35M	-48.2%
Sep 2023	-$192.51M	-13.8%
Jun 2023	-$169.21M	-20.8%
Mar 2023	-$140.09M	+4.6%
Dec 2022	-$146.78M	+12.7%
Sep 2022	-$168.09M	-12.6%
Jun 2022	-$149.30M	-37.1%
Mar 2022	-$108.86M	+39.3%
Dec 2021	-$179.33M	-27.4%
Sep 2021	-$140.81M	-11.1%
Jun 2021	-$126.77M	-13.9%
Mar 2021	-$111.32M	-5.2%
Dec 2020	-$105.85M	-21.4%
Sep 2020	-$87.22M	-209.8%
Jun 2020	-$28.15M	-580.6%
Mar 2020	$5.86M	-88.3%
Dec 2019	$49.91M	-23.9%
Sep 2019	$65.63M	+45.9%
Jun 2019	$44.97M	+323.2%
Mar 2019	$10.63M	+140.2%
Dec 2018	-$26.44M	+48.4%
Sep 2018	-$51.24M	-1.7%
Jun 2018	-$50.39M	-25.4%
Mar 2018	-$40.20M	-28.6%
Dec 2017	-$31.26M	+3.2%
Sep 2017	-$32.31M	+32.7%
Jun 2017	-$47.97M	+22.6%
Mar 2017	-$61.94M	+20.0%
Dec 2016	-$77.46M	+5.9%
Sep 2016	-$82.29M	-2.9%
Jun 2016	-$80.01M	-4.3%
Mar 2016	-$76.74M	-1.9%
Dec 2015	-$75.32M	+7.7%
Sep 2015	-$81.60M	-6.5%
Jun 2015	-$76.65M	-3.8%
Mar 2015	-$73.83M	-12.5%
Dec 2014	-$65.60M	-38.5%
Sep 2014	-$47.38M	-31.5%
Jun 2014	-$36.03M	-27.6%
Mar 2014	-$28.23M	-26.3%
Dec 2013	-$22.35M	-11.2%
Sep 2013	-$20.11M	-6.6%
Jun 2013	-$18.86M	+8.5%
Mar 2013	-$20.61M	-2.5%
Dec 2012	-$20.12M	-4.4%

Month	Value	Change
Sep 2012	-$19.27M	-12.1%
Jun 2012	-$17.19M	-37.4%
Mar 2012	-$12.51M	-27.4%
Dec 2011	-$9.82M	-36.5%
Sep 2011	-$7.19M	-8.7%
Jun 2011	-$6.61M	+5.5%
Mar 2011	-$6.99M	+4.1%
Dec 2010	-$7.29M	+14.1%
Sep 2010	-$8.49M	+10.1%
Jun 2010	-$9.45M	+1.4%
Mar 2010	-$9.58M	+10.5%
Dec 2009	-$10.71M	+21.3%
Sep 2009	-$13.62M	+37.7%
Jun 2009	-$21.85M	+25.3%
Mar 2009	-$29.25M	+11.0%
Dec 2008	-$32.85M	+4.7%
Sep 2008	-$34.46M	-0.3%
Jun 2008	-$34.36M	+9.3%
Mar 2008	-$37.88M	+3.6%
Dec 2007	-$39.30M	-6.4%
Sep 2007	-$36.94M	-11.6%
Jun 2007	-$33.09M	-36.7%
Mar 2007	-$24.20M	-22.4%
Dec 2006	-$19.77M	-2.2%
Sep 2006	-$19.35M	-43.4%
Jun 2006	-$13.50M	-8.7%
Mar 2006	-$12.42M	-18.0%
Dec 2005	-$10.52M	-23.0%
Sep 2005	-$8.55M	-2.8%
Jun 2005	-$8.32M	-44.8%
Mar 2005	-$5.75M	-30.4%
Dec 2004	-$4.41M	-63.6%
Sep 2004	-$2.69M	-108.8%
Jun 2004	-$1.29M	-81.9%
Mar 2004	-$709.40K	-244.2%
Dec 2003	-$206.10K	-118.3%
Sep 2003	-$94.40K	-39.2%
Jun 2003	-$67.80K	+31.0%
Mar 2003	-$98.30K	-5.8%
Dec 2002	-$92.90K	-5.6%
Sep 2002	-$88.00K	+5.0%
Jun 2002	-$92.60K	-44.2%
Mar 2002	-$64.20K	+2.1%
Dec 2001	-$65.60K	+10.0%
Sep 2001	-$72.90K	+26.0%
Jun 2001	-$98.50K	+5.4%
Mar 2001	-$104.10K	-0.4%
Dec 2000	-$103.70K	-2.1%
Sep 2000	-$101.60K	-36.9%
Jun 2000	-$74.20K	-6.5%
Mar 2000	-$69.70K	-15.2%
Dec 1999	-$60.50K	-104.4%
Sep 1999	-$29.60K	+3.9%
Jun 1999	-$30.80K	-116.9%
Mar 1999	-$14.20K	-

FAQ

What is the current TTM EBITDA of ARWR?: As of today, ARWR TTM EBITDA is -$200.64M
What is ARWR TTM EBITDA most recent change?: ARWR TTM EBITDA was down -2.09% on June 30, 2026
What is 1-year change in ARWR TTM EBITDA?: ARWR TTM EBITDA is down -134.95% year-over-year
How far is ARWR TTM EBITDA from its all-time high?: ARWR TTM EBITDA is currently -161.61% below its historical high of $325.65M set on December 31, 2025
How does ARWR TTM EBITDA rank versus sector peers?: ARWR TTM EBITDA is higher than 8.16% of companies in Healthcare sector
When is ARWR next earnings release?: The next earnings release for ARWR is on November 24, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

ARWR Official Website arrowheadpharma.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr